|
Volumn 12, Issue 10, 2012, Pages 7739-7746
|
Differential immunomodulating effects of pegylated liposomal doxorubicin nanoparticles on human macrophages
a,e a,b c,d f h a,f,g |
Author keywords
Caelyx; Lipo Dox; Liposomal Doxorubicin; Macrophage
|
Indexed keywords
CAELYX;
CELL VIABILITY;
CLINICAL OUTCOME;
CLINICAL TRIAL;
COCULTURE;
DIFFERENTIAL EFFECT;
DOXORUBICIN;
DRUG UPTAKE;
HUMAN MACROPHAGES;
IMMUNE FUNCTION;
IN-VIVO;
IN-VIVO EXPERIMENTS;
LIPO-DOX;
LIPOSOMAL DOXORUBICIN;
MEMBRANE INTEGRITY;
MONONUCLEAR PHAGOCYTE SYSTEMS;
MORPHOLOGICAL OBSERVATIONS;
PERIPHERAL BLOOD;
PHOSPHATIDYLCHOLINE;
PHOSPHOLIPID BILAYER;
SOYBEAN PHOSPHATIDYLCHOLINE;
ANTIGEN-ANTIBODY REACTIONS;
CELL CULTURE;
CELL MEMBRANES;
FLOW CYTOMETRY;
NANOPARTICLES;
PHOSPHOLIPIDS;
MACROPHAGES;
ANTINEOPLASTIC AGENT;
DOXORUBICIN;
IMMUNOLOGICAL ADJUVANT;
LIPOSOME;
MACROGOL DERIVATIVE;
NANOPARTICLE;
ARTICLE;
CELL CULTURE;
CHEMISTRY;
DRUG EFFECT;
HUMAN;
IMMUNOLOGY;
MACROPHAGE;
PHAGOCYTOSIS;
ADJUVANTS, IMMUNOLOGIC;
ANTINEOPLASTIC AGENTS;
CELLS, CULTURED;
DOXORUBICIN;
HUMANS;
LIPOSOMES;
MACROPHAGES;
NANOPARTICLES;
PHAGOCYTOSIS;
POLYETHYLENE GLYCOLS;
MLCS;
MLOWN;
|
EID: 84870832352
PISSN: 15334880
EISSN: 15334899
Source Type: Journal
DOI: 10.1166/jnn.2012.6644 Document Type: Article |
Times cited : (7)
|
References (18)
|